Janssen personally; company code R 1625, made 11 February 1958 and in Belgian clinical trials the same year. He is first author on the 1959 J Med Pharm Chem paper reporting the synthesis and screening of the butyrophenone series. Still on the WHO Essential Medicines list.
packagingUS single-dose vial of Haloperidol Injection USP 5 mg per mL: amber glass with a yellow flip cap, labeled for intramuscular use. Intropin (Mark Oniffrey) ·CC BY-SApackagingCzech glass ampoule of Haloperidol-Richter injection solution (haloperidolum), the break-neck single-dose form used in clinical settings. Wesalius ·CC BYpackagingPolish dropper bottle of Haloperidol UNIA 2 mg/mL oral drops — haloperidol is also dispensed as an oral solution, not only tablets and injections. PanSG ·CC BY-SA
